What's new

TAP 32, Clinical Drug Testing in Primary Care
This TAP is for clinical practitioners who provide primary care in office settings and community health centers. The publication provides information that practitioners need when deciding whether to introduce drug testing in their practices, and gives guidance on implementing drug testing.

Click here for the TAP Series page.

Anger Management for Substance Abuse and Mental Health Clients: A Cognitive Behavioral Therapy Manual
This manual is now available in Korean. This manual helps counselors teach anger management techniques in a group setting through a 12-week cognitive behavioral intervention (participants use the accompanying workbook, see below). It describes the anger cycle, conflict resolution, assertiveness skills, and anger control plans.

Click here for the Multi-language initiative page.

Anger Management for Substance Abuse and Mental Health Clients: Participant Workbook
This workbook is now available in Korean. It provides worksheets and homework assignments using the core concepts of the 12-week group cognitive behavioral therapy provided in the accompanying manual.

Click here for the Multi-language initiative page.

The Role of Biomarkers in the Treatment of Alcohol Use Disorders, 2012 Revision
This Advisory is a revision of the 2006 Substance Abuse Treatment Advisory, The Role of Biomarkers in the Treatment of Alcohol Use Disorders. Biomarkers are physiological signs of alcohol exposure or ingestion and may indicate a person has an alcohol use disorder. The Advisory reviews recent scientific information about biomarkers and discusses their relevance for clinical and medical purposes. In addition, it presents information about the use of biomarkers in treatment, their limitations, and the positive and negative aspects of each biomarker.

Click here for the Advisory page.

An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People With Opioid Dependence
This Advisory provides a brief introduction to extended-release injectable naltrexone as a treatment for opioid dependence. It is a long-acting pharmacological treatment option that is available in healthcare settings where agonist treatments may not be available and for people with opioid dependence who have not succeeded with or prefer not to take methadone or buprenorphine.

Click here for the Advisory page.

TIP 53: Addressing Viral Hepatitis in People With Substance Use Disorders
This TIP will enable behavioral health professionals who provide substance abuse treatment to: understand the implications of a diagnosis of hepatitis; educate, counsel, and support clients and their families; evaluate a program’s hepatitis information and practices; implement hepatitis screening; educate healthcare professionals about substance use disorder treatment in relation to hepatitis prevention and treatment; and establish cross-referral, consultation, and reporting networks with other healthcare providers.

Click here for the TIP Series page.

TIP 54: Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders
This TIP is for primary care providers who treat adult patients with or in recovery from substance use disorders (SUDs) who have chronic noncancer pain (CNCP). It provides readers with information about assessing patients with CNCP, screening patients for SUDs, managing addiction risk, monitoring patient adherence to treatment, and making referrals for further evaluation. Topics also include treating CNCP in patients on medication-assisted recovery, treating patients with active addiction, and treating patients with other behavioral health issues.

Click here for the TIP Series page.

Rapid HIV Testing in Substance Abuse Treatment Facilities
Rapid HIV tests are screening tests used to detect HIV infection that provide negative results and preliminary positive results in minutes, much faster than traditional HIV testing. These rapid tests can help substance abuse treatment facilities quickly identify clients who may have HIV infection so that the facilities can refer clients to or provide appropriate treatment.

Click here for the Advisory page.

Substance Use Disorders in People With Physical and Sensory Disabilities
Many people with physical and sensory disabilities have substance use disorders (SUDs) and may face barriers to SUD treatment. This In Brief is intended to help vocational rehabilitation professionals, physical therapists, and others who work with people with physical and sensory disabilities better understand SUDs and assist their clients in finding accessible SUD treatment services.

Click here for the In Brief page.

Tobacco Use Cessation During Substance Abuse Treatment Counseling
This Advisory offers substance abuse treatment counselors a brief introduction to tobacco use cessation techniques that can be used during substance abuse treatment and provides resources for additional information on the topic. The companion serial, Tobacco Use Cessation Policies in Substance Abuse Treatment: Administrative Issues (SMA 11-4636Admin), provides program administrators with information about implementing tobacco-free policies and practices in treatment settings.

Click here for the Advisory page.

Tobacco Use Cessation Policies in Substance Abuse Treatment: Administrative Issues
This Advisory provides program administrators with a brief introduction to implementing tobacco-free policies and practices in treatment settings. The companion serial, Tobacco Use Cessation During Substance Abuse Treatment Counseling (SMA-11-4636Clin), provides information for counselors.

Click here for the Advisory page.

El Alcohol y la Depreción: El Camino de Jorge Hacia Una Vida Mejor
Based on TIP 42, Substance Abuse Treatment for Persons With Co-Occurring Disorders (COD), this Spanish-language fotonovela employs believable characters and dialogue to tell a story that educates readers about co-occurring substance use and mental disorders and their treatment.

Click here for the Multi-Language Initiative page.